This segment encompasses the operation of seven private hospitals and affiliated ambulatory clinics across eight metropolitan areas in China, including four 1st tier cities. The focus is on providing comprehensive medical services, including inpatient care with 700 licensed beds, outpatient consultations, and specialized treatments. Research and development activities include the integration of advanced technologies such as robotic joint replacements. Patient impact is significant, offering access to high-quality healthcare services and improving patient outcomes. Market positioning is premium, targeting affluent patients seeking international standard care. Future opportunities include expansion into new markets and the adoption of cutting-edge medical technologies. Regulatory compliance is crucial, adhering to Chinese healthcare regulations and international standards. Partnerships with medical device companies and pharmaceutical firms are essential for providing advanced treatments.